- Home
- HUDI vs OMGA Comparison
HUDI vs OMGA Comparison
Compare HUDI & OMGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUDI
- OMGA
- Stock Information
- Founded
- HUDI 2018
- OMGA 2017
- Country
- HUDI China
- OMGA United States
- Employees
- HUDI N/A
- OMGA N/A
- Industry
- HUDI Steel/Iron Ore
- OMGA Biotechnology: Pharmaceutical Preparations
- Sector
- HUDI Industrials
- OMGA Health Care
- Exchange
- HUDI Nasdaq
- OMGA Nasdaq
- Market Cap
- HUDI 23.1M
- OMGA 27.1M
- IPO Year
- HUDI 2021
- OMGA 2021
- Fundamental
- Price
- HUDI $1.57
- OMGA $0.16
- Analyst Decision
- HUDI
- OMGA Strong Buy
- Analyst Count
- HUDI 0
- OMGA 5
- Target Price
- HUDI N/A
- OMGA $9.20
- AVG Volume (30 Days)
- HUDI 32.0K
- OMGA 26.1M
- Earning Date
- HUDI 02-28-2025
- OMGA 03-27-2025
- Dividend Yield
- HUDI N/A
- OMGA N/A
- EPS Growth
- HUDI N/A
- OMGA N/A
- EPS
- HUDI 0.01
- OMGA N/A
- Revenue
- HUDI $74,270,429.00
- OMGA $8,095,000.00
- Revenue This Year
- HUDI N/A
- OMGA $181.38
- Revenue Next Year
- HUDI N/A
- OMGA N/A
- P/E Ratio
- HUDI $163.02
- OMGA N/A
- Revenue Growth
- HUDI N/A
- OMGA 185.04
- 52 Week Low
- HUDI $1.47
- OMGA $0.10
- 52 Week High
- HUDI $3.45
- OMGA $4.46
- Technical
- Relative Strength Index (RSI)
- HUDI 43.70
- OMGA 31.40
- Support Level
- HUDI $1.56
- OMGA $0.15
- Resistance Level
- HUDI $1.74
- OMGA $0.25
- Average True Range (ATR)
- HUDI 0.10
- OMGA 0.08
- MACD
- HUDI 0.01
- OMGA 0.01
- Stochastic Oscillator
- HUDI 30.93
- OMGA 16.02
About HUDI Huadi International Group Co. Ltd.
Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.
About OMGA Omega Therapeutics Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.